COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim

COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim

Chemotherapy-induced febrile neutropenia (FN) is a medical emergency that causes severe adverse effects and death. Respiratory infections are one of the main causes of fever in patients with FN. We studied whether infection prevention and control (IPC) guidance for coronavirus 2019 disease reduced t...

Full description

Bibliographic Details
Main Authors: Hongki Gwak, Seung-Taek Lim, Ye-Won Jeon, Hyung Soon Park, Seong Hwan Kim, Young-Jin Suh
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
infection prevention
febrile neutropenia
breast cancer
Online Access:https://www.mdpi.com/2077-0383/11/23/7053

Similar Items

Similar Items